Martin & Co’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1M | Sell |
41,645
-46
| -0.1% | -$1.2K | 0.16% | 96 |
|
|
2026
Q1 | $1.17M | Buy |
41,691
+356
| +0.9% | +$9.48K | 0.2% | 93 |
|
|
2025
Q4 | $1.03M | Buy |
41,335
+1,635
| +4% | +$41.2K | 0.18% | 95 |
|
|
2025
Q3 | $1.01M | Buy |
39,700
+276
| +0.7% | +$6.81K | 0.18% | 95 |
|
|
2025
Q2 | $956K | Buy |
39,424
+333
| +0.9% | +$7.77K | 0.18% | 97 |
|
|
2025
Q1 | $991K | Buy |
39,091
+851
| +2% | +$22.3K | 0.19% | 97 |
|
|
2024
Q4 | $1.01M | Sell |
38,240
-2,645
| -6% | -$71.7K | 0.25% | 94 |
|
|
2024
Q3 | $1.18M | Sell |
40,885
-12
| -0% | -$350 | 0.28% | 96 |
|
|
2024
Q2 | $1.14M | Sell |
40,897
-2,082
| -5% | -$57.3K | 0.29% | 92 |
|
|
2024
Q1 | $1.19M | Sell |
42,979
-1,142
| -3% | -$31.7K | 0.29% | 93 |
|
|
2023
Q4 | $1.27M | Sell |
44,121
-2,219
| -5% | -$67.1K | 0.31% | 89 |
|
|
2023
Q3 | $1.54M | Buy |
46,340
+1,229
| +3% | +$43.5K | 0.4% | 82 |
|
|
2023
Q2 | $1.65M | Sell |
45,111
-2,136
| -5% | -$83.1K | 0.42% | 78 |
|
|
2023
Q1 | $1.93M | Sell |
47,247
-797
| -2% | -$34.4K | 0.5% | 71 |
|
|
2022
Q4 | $2.46M | Buy |
48,044
+1,187
| +3% | +$56.9K | 0.65% | 59 |
|
|
2022
Q3 | $2.05M | Buy |
46,857
+1,115
| +2% | +$54.2K | 0.61% | 62 |
|
|
2022
Q2 | $2.4M | Buy |
45,742
+404
| +0.9% | +$20.6K | 0.68% | 56 |
|
|
2022
Q1 | $2.35M | Sell |
45,338
-3,290
| -7% | -$171K | 0.6% | 59 |
|
|
2021
Q4 | $2.87M | Sell |
48,628
-228
| -0.5% | -$11.3K | 0.66% | 49 |
|
|
2021
Q3 | $2.1M | Buy |
48,856
+3,800
| +8% | +$168K | 0.49% | 69 |
|
|
2021
Q2 | $1.76M | Sell |
45,056
-1,897
| -4% | -$73.8K | 0.44% | 76 |
|
|
2021
Q1 | $1.7M | Sell |
46,953
-772
| -2% | -$27.4K | 0.43% | 74 |
|
|
2020
Q4 | $1.76M | Sell |
47,725
-2,493
| -5% | -$91.4K | 0.45% | 73 |
|
|
2020
Q3 | $1.75M | Sell |
50,218
-822
| -2% | -$28.8K | 0.51% | 65 |
|
|
2020
Q2 | $1.58M | Buy |
51,040
+1,409
| +3% | +$47.9K | 0.49% | 70 |
|
|
2020
Q1 | $1.54M | Buy |
49,631
+1,069
| +2% | +$36.4K | 0.55% | 62 |
|
|
2019
Q4 | $1.8M | Buy |
48,562
+53
| +0.1% | +$1.89K | 0.52% | 71 |
|
|
2019
Q3 | $1.65M | Sell |
48,509
-559
| -1% | -$20.3K | 0.5% | 77 |
|
|
2019
Q2 | $2.02M | Sell |
49,068
-933
| -2% | -$37K | 0.6% | 62 |
|
|
2019
Q1 | $2.02M | Buy |
50,001
+1,010
| +2% | +$40.4K | 0.61% | 59 |
|
|
2018
Q4 | $2.03M | Sell |
48,991
-290
| -0.6% | -$12K | 0.72% | 49 |
|
|
2018
Q3 | $2.06M | Sell |
49,281
-601
| -1% | -$23.1K | 0.62% | 63 |
|
|
2018
Q2 | $1.72M | Sell |
49,882
-411
| -0.8% | -$14K | 0.55% | 70 |
|
|
2018
Q1 | $1.69M | Sell |
50,293
-826
| -2% | -$28.4K | 0.56% | 70 |
|
|
2017
Q4 | $1.76M | Buy |
51,119
+327
| +0.6% | +$11.2K | 0.56% | 78 |
|
|
2017
Q3 | $1.72M | Sell |
50,792
-3,821
| -7% | -$123K | 0.56% | 78 |
|
|
2017
Q2 | $1.74M | Buy |
54,613
+939
| +2% | +$29.6K | 0.54% | 76 |
|
|
2017
Q1 | $1.74M | Sell |
53,674
-69,186
| -56% | -$2.18M | 0.55% | 73 |
|
|
2016
Q4 | $3.79M | Sell |
122,860
-2,873
| -2% | -$87.7K | 1.23% | 31 |
|
|
2016
Q3 | $4.04M | Buy |
125,733
+511
| +0.4% | +$17.1K | 1.33% | 28 |
|
|
2016
Q2 | $4.18M | Sell |
125,222
-5,227
| -4% | -$167K | 1.35% | 28 |
|
|
2016
Q1 | $3.67M | Sell |
130,449
-2,414
| -2% | -$69K | 1.17% | 35 |
|
|
2015
Q4 | $4.07M | Sell |
132,863
-1,159
| -0.9% | -$36.5K | 1.3% | 33 |
|
|
2015
Q3 | $3.99M | Buy |
134,022
+1,918
| +1% | +$61.5K | 1.34% | 31 |
|
|
2015
Q2 | $4.2M | Buy |
132,104
+1,728
| +1% | +$56.3K | 1.38% | 28 |
|
|
2015
Q1 | $4.3M | Buy |
130,376
+986
| +0.8% | +$31.3K | 1.38% | 31 |
|
|
2014
Q4 | $3.82M | Buy |
129,390
+1,829
| +1% | +$52.4K | 1.21% | 38 |
|
|
2014
Q3 | $3.58M | Buy |
127,561
+1,112
| +0.9% | +$31.2K | 1.19% | 40 |
|
|
2014
Q2 | $3.56M | Buy |
126,449
+1,132
| +0.9% | +$32.3K | 1.15% | 39 |
|
|
2014
Q1 | $3.82M | Sell |
125,317
-312
| -0.2% | -$9.3K | 1.31% | 34 |
|
|
2013
Q4 | $3.65M | Sell |
125,629
-859
| -0.7% | -$25K | 1.25% | 34 |
|
|
2013
Q3 | $3.45M | Sell |
126,488
-267
| -0.2% | -$7.26K | 1.24% | 34 |
|
|
2013
Q2 | $3.37M | Buy |
+126,755
| New | +$3.5M | 1.21% | 36 |
|
Other funds holding PFE
Martin & Co's PFE Position: Q2 2026 in Review
Martin & Co reduced its Pfizer (PFE) stake by 0.11% in Q2 2026, selling an estimated $1.2K and leaving 41,645 shares worth $1M. The position accounts for 0.16% of the portfolio, ranked #96.
Martin & Co first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.3M in Q1 2015. 2,824 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Martin & Co held 41,645 shares of Pfizer worth $1M as of Q2 2026.
- Martin & Co sold 46 Pfizer shares in Q2 2026, an estimated $1.2K.
- Pfizer made up 0.16% of Martin & Co's portfolio in Q2 2026, its #96 holding.
- Martin & Co first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Martin & Co's Pfizer position peaked at $4.3M in Q1 2015.
- 2,824 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Martin & Co's 13F filing for Q2 2026, filed 12 Aug 2026.